NEW YORK (GenomeWeb News) – Waters said today in a document filed with the US Securities and Exchange Commission that it entered into an Incremental Commitment Agreement to increase its revolving facility to $900 million from $700 million.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.
A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.
Researchers report in Nature this week that farming led to genomic adaptations in humans.
The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.